Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

vinblastine

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Tubulin inhibitor

Related drugs:

‹

›

No biomarker	Hodgkin Lymphoma	No biomarker	Hodgkin Lymphoma	vinblastine Sensitive: A2 - Guideline vinblastine Sensitive : A2	vinblastine Sensitive: A2 - Guideline vinblastine Sensitive : A2
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	methotrexate + vinblastine Sensitive: A2 - Guideline methotrexate + vinblastine Sensitive : A2	methotrexate + vinblastine Sensitive: A2 - Guideline methotrexate + vinblastine Sensitive : A2
RNASET2 overexpression	Clear Cell Renal Cell Carcinoma	RNASET2 overexpression	Clear Cell Renal Cell Carcinoma	vinblastine Sensitive: C3 – Early Trials vinblastine Sensitive : C3	vinblastine Sensitive: C3 – Early Trials vinblastine Sensitive : C3